Veritas Pharma Inc.
Veritas has developed intellectual property and clinical data relating to various cannabis strains and products. It is the Company’s aim to advance the science behind medicinal cannabis, by developing cannabis-based treatments for specific disease conditions. The Company is also focused on investigating opportunities to acquire income-producing assets in the cannabis industry. Moreover, Veritas intends to leverage its management expertise to enter into mergers and acquisitions with suitable cannabis-industry participants, with a view to generating revenue while continuing its research and development opportunities.
Veritas Pharma Inc. (VRT)
Le 8 février/February 2019
Veritas Pharma Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post-consolidation share for each ten (10) pre-consolidation common shares.
As a result, the outstanding shares of the company will be reduced to approximately 12,157,399.